−59.4
Monte Rosa Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
−92.5
FY23:
−43.8
FY24:
42.0
FY25:
−22.8
Change from FY21 to FY25
millions USD
FY21:
−9.65
FY22:
−219
FY23:
88.8
FY24:
−44.5
FY25:
−102
Change from FY21 to FY25
millions USD
FY21:
378
FY22:
20.5
FY23:
27.5
FY24:
98.9
FY25:
30.4
millions USD
FY21:
309
FY22:
−291
FY23:
72.5
FY24:
96.4
FY25:
−94.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
−69.1
FY22:
−105
FY23:
−62.8
FY24:
38.0
FY25:
−27.5
All amounts in millions USD